Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS AND CONTINGENCIES (Details Narrative)

v3.23.3
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Sep. 19, 2023
Nov. 16, 2021
Dec. 31, 2022
Sep. 30, 2023
Subsidiary, Sale of Stock [Line Items]        
Offering price per share       $ 10.60
Waived deferred underwriting fee     $ 342,975  
Accrued contingent legal costs     2,066,035 $ 4,522,137
Business combination acquisition related costs $ 7,000,000      
Retained Earnings [Member]        
Subsidiary, Sale of Stock [Line Items]        
Waived deferred underwriting fee     $ 6,655,361  
Underwriting Agreement [Member]        
Subsidiary, Sale of Stock [Line Items]        
Underwriter cash discount per unit   $ 0.20    
Payment of underwriting commissions   $ 3,999,049    
Deferred fee   $ 0.35    
Deferred underwriting fee   $ 6,998,336    
Over-Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Purchase of additional shares   2,495,246   2,625,000
Offering price per share   $ 10.00    
Proceeds from shares   $ 24,952,460